BioLife Solutions, Inc. (BLFS)
38.61
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
BioLife Solutions Free Cash Flow (Quarterly) : 5.185M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.185M |
| March 31, 2026 | -0.658M |
| December 31, 2025 | 0.658M |
| September 30, 2025 | 2.802M |
| June 30, 2025 | 5.625M |
| March 31, 2025 | 1.552M |
| December 31, 2024 | 0.583M |
| September 30, 2024 | 3.688M |
| June 30, 2024 | 5.464M |
| March 31, 2024 | -4.831M |
| December 31, 2023 | 1.33M |
| September 30, 2023 | -5.875M |
| June 30, 2023 | -8.327M |
| March 31, 2023 | -6.007M |
| December 31, 2022 | 3.409M |
| September 30, 2022 | -0.95M |
| June 30, 2022 | -11.95M |
| March 31, 2022 | -9.38M |
| December 31, 2021 | -2.34M |
| September 30, 2021 | -0.329M |
| June 30, 2021 | -9.737M |
| March 31, 2021 | -0.572M |
| December 31, 2020 | -2.006M |
| September 30, 2020 | -0.621M |
| June 30, 2020 | 4.098M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.541M |
| December 31, 2019 | -1.322M |
| September 30, 2019 | 1.047M |
| June 30, 2019 | -0.333M |
| March 31, 2019 | 1.146M |
| December 31, 2018 | 0.4246M |
| September 30, 2018 | 0.5316M |
| June 30, 2018 | 0.5411M |
| March 31, 2018 | 0.3508M |
| December 31, 2017 | 0.7507M |
| September 30, 2017 | 0.0611M |
| June 30, 2017 | -0.1439M |
| March 31, 2017 | -0.2065M |
| December 31, 2016 | -0.9377M |
| September 30, 2016 | -1.077M |
| June 30, 2016 | -1.397M |
| March 31, 2016 | -2.173M |
| December 31, 2015 | -1.689M |
| September 30, 2015 | -1.598M |
| June 30, 2015 | -1.258M |
| March 31, 2015 | -1.349M |
| December 31, 2014 | -1.039M |
| September 30, 2014 | -0.8474M |
| June 30, 2014 | -0.9524M |
| March 31, 2014 | -0.9129M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Repligen Corp. | 26.70M |
| Agilent Technologies, Inc. | 439.00M |
| Danaher Corp. | 1.265B |
| Thermo Fisher Scientific, Inc. | 1.675B |
| West Pharmaceutical Services, Inc. | 80.80M |